Total Results: 16298
Right After Trump Blamed High Drug Prices On Campaign Cash, Drugmakers Gave More
At a political rally in March, President Donald Trump said drug prices are “outrageous” and blamed campaign contributions. Drugmakers funneled nearly $280,000 to Congress the very next day.
Congress’ Cold Shoulder Sends Shivers Through Community Health Centers
The clinics, which serve many poor people, are tightening spending in case Congress doesn’t approve new funding for them before the government’s 2018 fiscal year starts Sunday.
Media outlets report on news from Florida, Indiana, Connecticut, California, Georgia and Kansas.
Need An MRI? Anthem Directs Most Outpatients To Independent Centers
The insurer says hospital-based imaging services are too expensive and the independent facilities provide high-quality care.
Sen. Collins Announces Opposition To GOP Bill To Replace Obamacare
The statement from the Maine senator came after the Congressional Budget Office said the bill would cause millions of people to become uninsured.
Private Jets For Tom Price Grounded While Inspector General Investigates Travel Spending
“We’ve heard the criticism. We’ve heard the concerns. We take that very seriously and have taken it to heart,” says Health and Human Services Secretary Tom Price about reports that he has spent $300,000 on private airplanes for government travel.
Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don’t We?
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
Viewpoints: Nursing Homes And Hurricanes; Winning The War On Drugs
A selection of opinions on health care from around the country.
Research Roundup: Hospital Transportation; Medicaid Expansion; Obesity Treatment
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Media outlets report on news from California, Florida, Texas, Illinois and Pennsylvania.
Drug’s $475K Cost Highlights Pricing Problems With Unique, Breakthrough Therapies
“We need a new payment model,” Steve Miller, chief medical officer at Express Scripts Holding Co., said while criticizing Novartis’ new drug.
Money-Saving Offer For Medicare’s Late Enrollees Is Expiring. Can They Buy Time?
Sept. 30 marks the end of Medicare’s temporary offer to waive penalties for certain late Medicare enrollees with Affordable Care Act insurance coverage.
To Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
Agency says a removable cap will lower the risk of antibiotic resistant infections but some experts see it as a modest step in curbing the sort of deadly outbreaks that occurred a few years ago.
High On Drugs? Anthem Cites Soaring Drug Costs To Justify 35% Rate Hike in California
The company’s drug spending prediction, far above other insurers in the individual market, has experts scratching their heads. Anthem cites market volatility.
Abre la boca y di “ahhh”: los dentistas tratan cada vez a niños más pequeños
Asociaciones de odontólogos recomiendan que los niños pequeños vayan al dentista antes de cumplir el año, o cuando se asoma el primer diente, para evitar un futuro lleno de caries.
Open Your Mouth And Say Goo-Goo: Dentists Treating Ever-Younger Patients
A shift in dental guidelines encourages first dental visits for infants as young as 6 months, or when the first baby teeth emerge. That makes some dentists uncomfortable.
Grassley Presses For Public Disclosure Of Hospital Inspections
The Wall Street Journal reports that Sen. Chuck Grassley (R-Iowa) is calling for more transparency regarding hospital inspection reports.
HHS Secretary Price Eschews Commercial Flights For Private Jet
Health and Human Services Secretary Tom Price is a frequent critic of federal spending who has been developing a plan for department-wide cost savings.
Different Takes: What To Do With CHIP; Deal With Threats To Obamacare Before Single Payer
News outlets examine a variety of pressing health policy issues, ranging from the reauthorization of the Children’s Health Insurance Program to what’s next for the Affordable Care Act.
Under Pressure To Reduce Red Tape, FDA To Hold Hearing On Approval Process
The Food and Drug Administration implemented a more structured approach to how new drugs are approved based on their safety risks as part of the reauthorization of the Prescription Drug User Fee Act in 2010. At the meeting, the agency will likely hear testimony on experiences with this approach.
